Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Aug 15, 2020; 12(8): 918-930
Published online Aug 15, 2020. doi: 10.4251/wjgo.v12.i8.918
Published online Aug 15, 2020. doi: 10.4251/wjgo.v12.i8.918
All, n = 142 | EMR group, n = 87 | ESD group, n = 55 | P value | |
Age, yr | ||||
Median (IQR) | 63.5 (57-71.75) | 62 (57-70) | 66 (59-73.5) | 0.15 |
Sex, n (%) | ||||
Male | 79 (55.6) | 56 (64.4) | 23 (41.8) | 0.01 |
Female | 63 (44.4) | 31 (35.6) | 32 (58.2) | |
Tumor location, n (%) | ||||
Bulbs | 32 (22.5) | 17 (19.5) | 15 (27.3) | 0.31 |
Second portion or later | 110 (77.5) | 70 (80.5) | 40 (72.7) | |
Morphology, n (%) | ||||
Flat or depressed | 28 (19.7) | 17 (19.5) | 11 (20.0) | 1 |
Protruded | 114 (80.3) | 70 (80.5) | 44 (80.0) | |
Tumor size, mm | ||||
Median (IQR) | 8 (5.25-15) | 7 (5-10) | 15 (10.5-20) | < 0.001 |
< 11 mm | 85 (59.9) | 71 (81.6) | 14 (25.5) | < 0.001 |
≥ 11 mm | 57 (40.1) | 16 (18.4) | 41 (74.5) | |
Tumor depth, n (%) | ||||
Mucosa | 139 (97.9) | 86 (98.9) | 53 (96.4) | 0.56 |
Submucosa | 3 (2.1) | 1 (1.1) | 2 (3.6) | |
Histology, n (%) | ||||
Adenoma | 103 (72.5) | 72 (82.8) | 31 (56.4) | 0.001 |
Adenocarcinoma | 39 (27.5) | 15 (17.2) | 24 (43.6) |
EMR group, n = 28 | ESD group, n = 28 | P value | ASD | |
Variable matching between groups | ||||
Age, yr; ≥ 65/< 65 | 8/20 | 6/22 | 0.76 | 0.17 |
Sex; male/female | 17/11 | 16/12 | 1 | 0.073 |
Tumor location; bulbs/others | 8/20 | 6/22 | 0.67 | 0.17 |
Morphology; protruded/flat or depressed | 22/6 | 23/5 | 1 | 0.090 |
Histology; adenocarcinoma/adenoma | 8/20 | 7/21 | 1 | 0.081 |
Tumor depth; mucosa/submucosa | 27/1 | 27/1 | 1 | 0 |
Tumor size; median (IQR) | 11 (6.25-15) | 10.5 (8-13) | 0.90 | 0.026 |
Tumor size; ≥ 11 mm/< 11 mm | 14/14 | 14/14 | 1 | 0 |
EMR group, n = 28 | ESD group, n = 28 | P value | |
Procedure time, min | |||
Median (IQR) | 6 (3-10.75) | 87.5 (68.5-136.5) | < 0.001 |
En bloc resection, n (%) | 23 (82.1) | 26 (92.9) | 0.42 |
Complete resection, n (%) | 20 (71.4) | 25 (89.3) | 0.18 |
Closure of mucosal defects, n (%) | 24 (85.7) | 27 (96.4) | 0.35 |
Adverse events, n (%) | 1 (3.6) | 5 (17.9) | 0.19 |
Intraoperative perforation, n (%) | 0 (0) | 3 (10.7) | 0.24 |
Delayed perforation, n (%) | 0 (0) | 1 (3.6) | 1 |
Delayed bleeding, n (%) | 1 (3.6) | 0 (0) | 1 |
Emergency surgery, n (%) | 0 (0) | 1 (3.6) | 1 |
Hospital stay, d | |||
Median (IQR) | 8 (6-10.75) | 11 (8.25-14.75) | 0.006 |
Follow-up duration, mo | 23 (11-35.5) | 24 (9.75-57.5) | 0.831 |
Median (IQR) | |||
One-year follow-up, n (%) | 21 (75) | 20 (71.4) | 1 |
Local recurrence, n (%) | 1 (3.6) | 0 (0) | 1 |
Metastatic recurrence, n (%) | 0 (0) | 0 (0) | - |
- Citation: Esaki M, Haraguchi K, Akahoshi K, Tomoeda N, Aso A, Itaba S, Ogino H, Kitagawa Y, Fujii H, Nakamura K, Kubokawa M, Harada N, Minoda Y, Suzuki S, Ihara E, Ogawa Y. Endoscopic mucosal resection vs endoscopic submucosal dissection for superficial non-ampullary duodenal tumors. World J Gastrointest Oncol 2020; 12(8): 918-930
- URL: https://www.wjgnet.com/1948-5204/full/v12/i8/918.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i8.918